Cargando…
Advancements in the treatment of differentiated thyroid cancer
Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the majority of thyroid malignancies. The threefold increase in DTC incidence over the last three decades has been largely attributed to advancements in detection of papillary thyroid microcarcinomas. Efforts...
Autores principales: | Stewart, Latoya A., Kuo, Jennifer H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975487/ https://www.ncbi.nlm.nih.gov/pubmed/33796254 http://dx.doi.org/10.1177/20420188211000251 |
Ejemplares similares
-
Medullary thyroid carcinoma: recent advances in identification,
treatment, and prognosis
por: Bartz-Kurycki, Marisa A., et al.
Publicado: (2021) -
Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021) -
Is eNAMPT/visfatin a potential serum marker of papillary thyroid
cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022) -
Clinical and molecular characterization of thyroid cancer when seen
as a second malignant neoplasm
por: Romanelli, Kristen, et al.
Publicado: (2021) -
Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)